Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire

被引：24

作者：

Brubaker, Linda ^{[1
]}

Khullar, Vik ^{[2
]}

Piault, Elisabeth ^{[3
]}

Evans, Christopher J. ^{[3
]}

Bavendam, Tamara ^{[4
]}

Beach, James ^{[5
]}

Yeh, Yating ^{[3
]}

Kopp, Zoe S. ^{[4
]}

Kelleher, Con J. ^{[6
]}

Trocio, Jeffrey ^{[4
]}

机构：

[1] Loyola Univ, Maywood, IL 60153 USA

[2] St Marys Hosp, London, England

[3] Mapi Values, Boston, MA USA

[4] Pfizer Inc, New York, NY USA

[5] Beach Clin Studies, Paradise Valley, AZ USA

[6] St Thomas Hosp, London, England

来源：

INTERNATIONAL UROGYNECOLOGY JOURNAL | 2011年 / 22卷 / 08期

关键词：

Antimuscarinic; Benign prostatic hyperplasia; Bladder outlet obstruction; Goal attainment scaling; Lower urinary tract symptoms; Overactive bladder; OVERACTIVE BLADDER; REPORTED OUTCOMES; IMPACT; PERSISTENCE; VALIDATION; WOMEN;

D O I：

10.1007/s00192-011-1382-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Introduction and hypothesis The Self-Assessment Goal Achievement (SAGA) questionnaire was developed to identify treatment goals and assess goal-achievement in patients with lower urinary tract symptoms (LUTS). Methods This study consisted of (1) gathering information on goal setting/attainment concepts, (2) goal elicitation (n(-)41 patients with LUTS), (3) cognitive debriefing of draft questionnaire (n(-)11), and (4) pilot testing (n(-)104). Results SAGA consists of baseline (goal-assessment; ranking) and follow-up (goal-achievement) modules. In addition to goals most frequently mentioned, patients can list up to five open goals. Goals most commonly reported as "very important" in pilot testing included reducing urgency (72%), incontinence (65%), and nocturia (64%). Treatment goals spontaneously reported as "very important" were reducing incontinence (45%), nocturia (40%), and frequency (26%). Conclusions SAGA may be used to identify treatment goals and assess goal-achievement in patients with LUTS in the clinic and for research (with additional validation). This information may promote patient-physician interaction and help patients establish realistic treatment goals, which may in turn improve treatment adherence and outcomes.

引用

页码：937 / 946

页数：10

共 30 条

[1]

[Anonymous], 2009, Fed Regist, V74, P65132

[2]

Goal attainment for spasticity management using botulinum toxin [J].

Ashford, Stephen ;

Turner-Stokes, Lynne .

PHYSIOTHERAPY RESEARCH INTERNATIONAL, 2006, 11 (01) :24-34

[3]

Patient-reported reasons for discontinuing overactive bladder medication [J].

Benner, Joshua S. ;

Nichol, Michael B. ;

Rovner, Eric S. ;

Jumadilova, Zhanna ;

Alvir, Jose ;

Hussein, Mohamed ;

Fanning, Kristina ;

Trocio, Jeffrey N. ;

Brubaker, Linda .

BJU INTERNATIONAL, 2010, 105 (09) :1276-1282

[4]

Brubaker L, 2007, INT CONT SOC ROTT NE

[5]

Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment [J].

Brubaker, Linda ;

Chapple, Christopher ;

Coyne, Karin S. ;

Kopp, Zoe .

UROLOGY, 2006, 68 (2A) :3-8

[6]

Charmaz K., 1996, RETHINKING METHODS P, P27, DOI [10.1016/B978-0-08-044894-7.01581-5, DOI 10.1016/B978-0-08-044894-7.01581-5, 10.4135/9781446221792.n3, DOI 10.4135/9781446221792.N3]

[7]

Charmaz Kathy., 1991, Good Days, Bad Days: The Self in Chronic Illness and Time

[8]

Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q [J].